CURIA revolutionising patient participation in cancer treatment – ET HealthWorld


Pune: Curia Created by Inoplexus AG, Has now become the most decentralized cancer information ecosystem internationally. With over 700,000+ downloads, CURIA is on a mission to revolutionize treatment travel and patient participation in clinical research for cancer.

Built up Performance Uses AI technology to search the Internet 95 percent daily for updates to platforms, app registries, drug approval sites, and clinical trial databases. The information compiled on the app is reviewed by an expert panel and provided to the app users in such a way that only information related to the patient’s cancer profile is displayed. This significantly reduces the time spent on search and eliminates the risk of misinformation.

Speaking about this, Dr. Gunjan Bhardwaj, founder, Innoplexus AG, said, “The app is now available in 12 geographic areas and is # 1 in the Play Store in many countries, including India. We have created many special features such as

‘Cancer twin’ refers to patients’ desire to connect with someone who fully understands their situation. Based on the questionnaire, the app’s AI algorithm matches patients with the most similar cancer profiles and enables the sharing of experiences through a private, blockchain encrypted chat service that ensures that patient privacy is not compromised.

Adding further, Ashwin Rathore, co-founder, OncoCoin AG, said, “We have recently launched a second opinion service in the application. In addition, the app has an integrated information feed feature that gives patients access to curated articles, blogs, audio / videos as well as other resources that can help them on their treatment journey. Day by day, we are moving closer to the goal of connecting with every cancer patient in the world and enabling better recovery for them. “

  हल्दी का एक हद से ज्यादा इस्तेमाल कर सकता है बीमार, हो सकती हैं ये गंभीर बीमारी

The application focuses on ensuring that no user lacks access to the best treatment options due to misinformation. The app has customized options that answer the three main concerns of most patients.

These are:
What treatment options are available to me?
What clinical trials can I benefit from?
Who are the experts to consult for my type of cancer?

CURIA seeks to answer these questions, and facilitates in-depth doctor-patient interactions to identify appropriate measures for patients. The app is available on both Android and iOS.

.



Source link

Leave a Comment